You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1689114 |
---|---|
Category | Small Molecules |
Description | SARS-CoV-2-IN-13 |
CAS Number | 56961-10-5 |
Purity | 98.15% |
MW | 327.12 |
SMILES | O=C(C1=CC(Cl)=CC=C1O)NC2=CC=C([N+]([O-])=O)C(Cl)=C2 |
Formula | C13H8Cl2N2O4 |
Biological Activity | SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1]. |
Storage | -20°C |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Filter by Rating